相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review
Yanju Bao et al.
CHANNELS (2015)
New insights of nociceptor sensitization in bone cancer pain
Baojin Hua et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Increased Expression of Protease-Activated Receptor 2 and 4 Within Dorsal Root Ganglia in a Rat Model of Bone Cancer Pain
Yanju Bao et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Protease-activated receptor 2 signalling pathways: a role in pain processing
Yanju Bao et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Involvement of Protease-Activated Receptor 2 in Nociceptive Behavior in a Rat Model of Bone Cancer
Yanju Bao et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain
Yanju Bao et al.
MOLECULAR PAIN (2014)
Activation of Mu Opioid Receptors Sensitizes Transient Receptor Potential Vanilloid Type 1 (TRPV1) via β-Arrestin-2-Mediated Cross-Talk
Matthew P. Rowan et al.
PLOS ONE (2014)
Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner
Viola Spahn et al.
PAIN (2013)
β-Arrestin-2 Desensitizes the Transient Receptor Potential Vanilloid 1 (TRPV1) Channel
Elaine D. Por et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold?
Kathryn A. DeFea
CELLULAR SIGNALLING (2011)
The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics
Kirsten M. Raehal et al.
NEUROPHARMACOLOGY (2011)
Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice
T-L. Nguyen et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Arresting a Transient Receptor Potential (TRP) Channel β-ARRESTIN 1 MEDIATES UBIQUITINATION AND FUNCTIONAL DOWN-REGULATION OF TRPV4
Arun K. Shukla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
Jeffrey J. Kovacs et al.
DEVELOPMENTAL CELL (2009)
Mdm2 Directs the Ubiquitination of β-Arrestin-sequestered cAMP Phosphodiesterase-4D5
Xiang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia
Anna Vardanyan et al.
JOURNAL OF PAIN (2009)
The Role of Mitogen-Activated Protein Kinase (MAPK) in Morphine Tolerance and Dependence
Yong Chen et al.
MOLECULAR NEUROBIOLOGY (2009)
A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1
Nathaniel A. Jeske et al.
PAIN (2009)
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Mark R. Hutchinson et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner
Xu Yue et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization
Irina Vetter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein kinase a anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons
Katrin Schnizler et al.
JOURNAL OF NEUROSCIENCE (2008)
Activation of TRPV1 contributes to morphine tolerance: Involvement of the mitogen-activated protein kinase signaling pathway
Yong Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Sustained Inhibition of Neurotransmitter Release from Nontransient Receptor Potential Vanilloid Type 1-Expressing Primary Afferents by μ-Opioid Receptor Activation-Enkephalin in the Spinal Cord
Hong-Yi Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150
Xuming Zhang et al.
NEURON (2008)
Phosphorylation of TRPV1 by neurokinin-1 receptor agonist exaggerates the capsaicin-mediated substance P release from cultured rat dorsal root ganglion neurons
He-Bin Tang et al.
NEUROPHARMACOLOGY (2008)
A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1
Nathaniel A. Jeske et al.
PAIN (2008)
Inhibition of Period1 Gene Attenuates the Morphine-Induced ERK-CREB Activation in Frontal Cortex, Hippocampus, and Striatum in Mice
Su-xia Li et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2008)
The activation of transient receptor potential vanilloid receptor subtype 1 by capsaicin without extracellular Ca2+ is involved in the mechanism of distinct substance P release in cultured rat dorsal root ganglion neurons
He-Bin Tang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons
Y. Niiyama et al.
NEUROSCIENCE (2007)
TRP channels: Targets for the relief of pain
Jon D. Levine et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Functional specialization of β-arrestin interactions revealed by proteornic analysis
Kunhong Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons
S. -R. Chen et al.
NEUROSCIENCE (2007)
mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain
Jeannette Endres-Becker et al.
MOLECULAR PHARMACOLOGY (2007)
New roles for β-arrestins in cell signaling:: Not just seven-transmembrane receptors
Robert J. Lefkowitz et al.
MOLECULAR CELL (2006)
Distinct populations of spinal cord lamina II interneurons expressing G-protein-gated potassium channels
Cheryl L. Marker et al.
JOURNAL OF NEUROSCIENCE (2006)
TRPV1: a therapeutic target for novel analgesic drugs?
Arpad Szallasi et al.
TRENDS IN MOLECULAR MEDICINE (2006)
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
M. Cui et al.
JOURNAL OF NEUROSCIENCE (2006)
Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb-Raf-1 pathways
Piyalli Dasgupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPVI responses through a cyclic AMP-dependent protein kinase A pathway
Irina Vetter et al.
MOLECULAR PAIN (2006)
TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation
Sarah C. Lappin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
GRKs and β-arrestins:: roles in receptor silencing, trafficking and signaling
Eric Reiter et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Loss of TRPV1-expressing sensory neurons reduces spinal μ opioid receptors but paradoxically potentiates opioid analgesia
SR Chen et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Blocking μ opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids
SR Chen et al.
BRAIN RESEARCH (2006)
Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance
Y Cui et al.
BRAIN RESEARCH (2006)
Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats
JL Cao et al.
PAIN (2005)
Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment
W Bilecki et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: Parallels with tolerance and dependence
GB Gu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The ERK/MAPK pathway, as a target for the treatment of neuropathic pain
WY Ma et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Role of NK-1 neurotransmission in opioid-induced hyperalgesia
T King et al.
PAIN (2005)
Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse
NM Breese et al.
PAIN (2005)
Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase
DP Mohapatra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sensitization of vanilloid receptor involves an increase in the phosphorylated form of the channel
SY Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Nociceptive transmitter release in the dorsal spinal cord by capsaicin-sensitive fibers after noxious gastric stimulation
R Schicho et al.
BRAIN RESEARCH (2005)
Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?
T King et al.
NEUROSIGNALS (2005)
Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure
MH Ossipov et al.
BIOPOLYMERS (2005)
MAPK activation in nociceptive neurons and pain hypersensitivity
K Obata et al.
LIFE SCIENCES (2004)
Mapk cascade signalling and synaptic plasticity
GM Thomas et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding
JY Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
[3H]resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution
JC Roberts et al.
BRAIN RESEARCH (2004)
Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization
ZY Zhuang et al.
JOURNAL OF NEUROSCIENCE (2004)
VR1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus
DP Li et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine
DL Muller et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts
M Ferrer-Alcón et al.
JOURNAL OF NEUROCHEMISTRY (2004)
NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia
F Amaya et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Antinociceptive and nociceptive actions of opioids
MH Ossipov et al.
JOURNAL OF NEUROBIOLOGY (2004)
Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway
DP Mohapatra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1)
G Bhave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea
HN Wenk et al.
PAIN (2003)
Capsaicin-induced hyperalgesia and μ-opioid-induced antihyperalgesia in male and female Fischer 344 rats
AC Barrett et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Attacking pain at its source:: new perspectives on opioids
C Stein et al.
NATURE MEDICINE (2003)
N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl) tetrahydropyrazine-1(2H)-carbox-amide(BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties:: II.: In vivo characterization in rat models of inflammatory and neuropathic pain
JD Pomonis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin
M Rigoni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons
F Amaya et al.
BRAIN RESEARCH (2003)
β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates β-adrenoceptor switching from Gs to Gi
GS Baillie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain
KM Walker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
mu-opioid receptors are located postsynaptically and endomorphin-1 inhibits voltage-gated calcium currents in premotor cardiac parasympathetic neurons in the rat nucleus ambiguus
M Irnaten et al.
NEUROSCIENCE (2003)
Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain
XL Fan et al.
NEUROSCIENCE (2003)
Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins
SJ Perry et al.
SCIENCE (2002)
p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia
RR Ji et al.
NEURON (2002)
cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation
G Bhave et al.
NEURON (2002)
Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions
C Abbadie et al.
BRAIN RESEARCH (2002)
Peripheral analgesic and antiinflammatory effects of opioids
C Stein et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2001)
Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse
SL Borgland et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons:: an in vitro and in vivo study
WY Ma et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal
Q Zhou et al.
NEUROPHARMACOLOGY (2001)
The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase
L De Petrocellis et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice
AM Salmon et al.
NATURE NEUROSCIENCE (2001)
Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity
C Tohda et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The vanilloid receptor: A molecular gateway to the pain pathway
MJ Caterina et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
KJ Powell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Rewarding effects of opiates are absent in mice lacking the receptor for substance P
P Murtra et al.
NATURE (2000)
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
MJ Caterina et al.
SCIENCE (2000)
Capsaicin receptor in the pain pathway
M Tominaga et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Opioid receptor endocytosis and activation of MAP kinase pathway
N Trapaidze et al.
MOLECULAR BRAIN RESEARCH (2000)
Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats
MCH Ko et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
